Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > EV / EBITDA (ltm)

Rhythm Pharmaceuticals Inc EV / EBITDA (ltm) Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly EV / EBITDA (ltm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Rhythm Pharmaceuticals Inc Market Cap for the quarter ending March 03, 2018 was $543m
  • Rhythm Pharmaceuticals Inc Price / Book for the quarter ending March 03, 2018 was 3.75
  • Rhythm Pharmaceuticals Inc Enterprise Value for the quarter ending March 03, 2018 was $395m
View Chart On Koyfin